Hostname: page-component-599cfd5f84-96rnj Total loading time: 0 Render date: 2025-01-07T07:12:46.495Z Has data issue: false hasContentIssue false
  • English
  • Français

Sustained Release Amitriptyline (Lentizol) in Depressive Illness

Published online by Cambridge University Press:  29 January 2018

John M. McGilchrist
John M. McGilchrist*
Affiliation:
William R. Warner & Co. Ltd. Eastleigh, Hants
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 122 , Issue 566 , January 1973 , pp. 119 - 120
Copyright
Copyright © Royal College of Psychiatrists, 1973 

References

Sims, A. G. P. (1972). ‘Trial of a sustained release form of amitriptyline in the treatment of depressive illness.’ Brit. J. Psychiat., 120, 65–7.CrossRefGoogle ScholarPubMed
Gomez, J. R., and Gomez, G. (1972).‘Depression in general practice. Comparison between thrice daily amitriptyline tablets and a single sustained-release capsule at night.’ Brit. J. clin. Pract., 26, 33–4.Google Scholar
Wheatley, D. (1972). ‘A long-acting amitrityline preparation.’ Practitioner. In press.Google Scholar
Sedman, G. (1973). ‘Trial of a sustained release form of amitriptyline (Lentizol) in the treatment of depressive illness.’ Brit. J. Psychiat. In press.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.